News Zoll agrees $538m deal to buy sleep apnoea specialist Itamar Itamar Medical was on the acquisition trail itself earlier this year, buying Spry Health to extend its sleep sensor technology range.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends